Oncopeptides Innovation AB
Records under this name other than the patents Oncopeptides Innovation AB holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 11 patents it holds.
Showing 1 to 1 of 1 · Back to Oncopeptides Innovation AB
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 6,992,207 | Melphalan derivatives and their use as cancer chemotherapeutic drugs Term ended Term ended Jun 25, 2022 · USPTO record | Term ended | Term ended Jun 25, 2022 | USPTO record |